We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

SPECT/CT in the Diagnosis of Dementia (DEMSPET)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01112501
First Posted: April 28, 2010
Last Update Posted: April 28, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
University of Eastern Finland
Information provided by:
Kuopio University Hospital
April 27, 2010
April 28, 2010
April 28, 2010
September 2006
January 2010   (Final data collection date for primary outcome measure)
Final diagnosis [ Time Frame: 4 years ]
(1) controls, (2) stable mild cognitive impairment (MCI), (3)MCI converted to Alzheimers's disease (AD), (4) frontotemporal dementia (FTD), suspected FTD converted to AD, (5) other final diagnoses
Same as current
No Changes Posted
Not Provided
Not Provided
Not Provided
Not Provided
 
SPECT/CT in the Diagnosis of Dementia
SPECT/CT in the Diagnosis of Dementia
Aim of the study is to evaluate whether Tc-99m-ECD-SPECT/CT enhances early diagnosis of dementia in two specific patient groups: (1) patient with mild cognitive impairment, and (2) patient with possible symptoms and signs of frontotemporal dementia. Evaluation of SPECT/CT data is performed both by visual and quantitative voxel-based analyses (Statistical Parametric Mapping). The final diagnosis is based on up to four years clinical follow-up.
Not Provided
Observational
Observational Model: Case Control
Time Perspective: Prospective
Not Provided
Not Provided
Probability Sample
Subjects with possible/suspected early dementia
Dementia
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
82
January 2010
January 2010   (Final data collection date for primary outcome measure)

Inclusion Criteria (one of these):

  • healthy control
  • mild cognitive impairment (recruited from a population based data)
  • clinically suspected frontotemporal dementia (unset diagnosis)

Exclusion Criteria:

  • unable to be scanned with SPECT/CT
Sexes Eligible for Study: All
Child, Adult, Senior
Yes
Contact information is only displayed when the study is recruiting subjects
Finland
 
 
NCT01112501
KUH5031339
Not Provided
Not Provided
Not Provided
Esko Vanninen / Professor, Kuopio University Hospital
Kuopio University Hospital
University of Eastern Finland
Not Provided
Kuopio University Hospital
April 2010